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Effective High-Level Disinfection of Cystoscopes:
Is Perfusion of Channels Required?
In the United States, more than 4 million cystoscopies are
performed each year. Cystoscopy is a diagnostic procedure that
uses an endoscope specially designed to examine the bladder,
lower urinary tract, and prostate gland or is used to collect
urine samples, perform biopsies, or remove small stones. A
flexible or rigid scope can be used to carry out the procedure.
Because the procedure involves a medical device in contact
with the patient’s mucous membranes, it is considered a
semicritical device that must, at a minimum, undergo high-
level disinfection. Failure to properly high-level disinfect or
sterilize equipment can lead to transmission of infection.1,2
The goal of this study was to examine the effectiveness
of complete immersion of a channeled endoscope versus
immersion plus perfusion of the high-level disinfectant into
the channel of the endoscope.
This study was conducted at the University of North
Carolina (UNC) Hospitals, an 840-bed academic medical
center. A flexible fiberscope (Model 7305, Richard Wolfe,
Vernon Hills, Indiana), which has an internal diameter of
2.5 mm and 400 mm working length, was used in this study.
The cystoscope channel was inoculated with 1 mL of a 0.5
McFarland test organism suspension and allowed to dry in a
biological safety cabinet in a horizontal position for 2 hours.
After 2 hours, the inoculating suspension was drained and the
scope was allowed to air dry in a vertical position for 24 hours.
After 24 hours, the endoscope was placed in an immersion
bath of 2.4% glutaraldehyde (Cidex, Advanced Sterilization
Products) for 20 minutes at room temperature. After
20 minutes, the scope was removed from the bath, and the
lumen of the scope was flushed and brushed with 15 mL of a
neutralizer (ie, 3% glycine with 0.1% Tween 80). After flushing
and brushing, serial dilutions of the “flush” solution were
made when significant levels of contamination were expected.
These serial dilutions were plated onto sheep blood agar plates
(BBL, Becton Dickinson Company, Sparks, MD) in duplicate
and incubated at 35–37°C for 48 hours. After 48 hours,
the plates were read and quantitated. When low-level con-
tamination was expected, the solution was filtered through an
analytical filter (0.2 µm, Thermo Scientific, Waltham, MA),
and the filter was then placed, aseptically, on sheep blood agar.
After each run, the scope was sterilized using ethylene oxide
(3M SteriVac, St. Paul, MN). The experiments were performed
in triplicate for each test organism and exposure condition.
Two cystoscopies were performed as controls for which high-
level disinfection was not conducted. The “passive” high-level
disinfection procedure involved fully immersing the cysto-
scope into a bath of 2.4% glutaraldehyde for 20 minutes at
room temperature, but no forced flow of the high-level
disinfectant into the endoscope channel was performed. A
minimum effective concentration of glutaraldehyde was
determined before each use (Comply Cold Sterilog, 3M Health
Care, St. Paul, MN). The “active” high-level disinfection was
conducted by attaching a luer-lock syringe to the port and
flushing glutaraldehyde back and forth through the port/
syringe until there were no bubbles in the interior lumen
of the scope or syringe. The syringe was left on the port
until disinfection was complete. The test organisms were
vancomycin-resistant Enterococcus or VRE (ATCC #51299)
and a carbapenem-resistant Enteriobacteriaceae (CRE),
Klebsiella pneumoniae (clinical isolate).
Our results demonstrated that disinfection (ie, a reduction
in bacterial load of greater than 7 log10 CFU) did not occur
unless the channel was actively perfused with the glutar-
aldehyde (Table 1). In fact, failure to perfuse the channel led to
only minimal, if any, reduction in bacterial contamination.
However, complete inactivation of 108 CFU of both VRE
and CRE was achieved when the channel was actively perfused.
It appears that no high-level disinfectant entered the channel
unless it was actively perfused because the level of microbial
contamination was not reduced by immersion. This occurs
because the air pressure in the channel is stronger than the
fluid pressure at the fluid–air interface. Recommendations are
provided for cystoscope high-level disinfection in Table 2 and
include actively perfusing the device while immersed in the
high-level disinfectant.
Endoscopes are valuable diagnostic and therapeutic tools;
however; many outbreaks have been linked to contaminated
medical devices such as gastrointestinal endoscopes.1–3
Cystoscopes have also been implicated as the source of
infection to multiple patients when incorrect disinfection
methods were identified.4 This may, in part, be related to
the lack of awareness of recommendations specifically for
disinfecting cystoscopes5 or failing to follow the manu-
facturer’s instructions, which specify perfusing the lumen
using a high-level disinfectant. Unfortunately, some cysto-
scope reprocessing recommendations published in the litera-
ture are incorrect. For example, authors have recommended
complete immersion of the cystoscope into the high-level
disinfectant but did not mention perfusion of the high-level
disinfectant into the channel.4 We suggest following our
recommendations (Table 2) and those of the American
Urological Association5 until evidence-based guidelines have
been published.
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“Passive”HLD (immersed, 3.6 × 108 5.0 × 107 3.2 × 108 3.1 × 108
not perfused) 2.9 × 108 1.0 × 108 1.8 × 109 4.6 × 108
1.1 × 108 6.8 × 107 4.1 × 108 1.0 × 108
“Active” HLD (perfused) 8.4 × 107 1 CFU 3.0 × 108 0
1.5 × 108 0 9.2 × 108 0
2.8 × 108 0 8.4 × 108 0
HLD, high-level disinfectant; CRE-carbapenem-resistant Enterobacteriaceae
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